Liquid-crystalline medium
US-2015048276-A1 · Feb 19, 2015 · US
US10457658B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10457658-B2 |
| Application number | US-201615753192-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 3, 2016 |
| Priority date | Aug 21, 2015 |
| Publication date | Oct 29, 2019 |
| Grant date | Oct 29, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.
Opening claim text (preview).
The invention claimed is: 1. An optically active intraocular lens article, which comprises a compound of formula (I) wherein a is 0 or 1; a′ is 0 or 1; R 1 , R 2 and R 3 are at each occurrence independently selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl; one of R 4 and R 5 is a group of formula (II) and the other of R 4 and R 5 is selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl, heteroaryl, and R 6 -Sp-[X 1 ] a *; * each indicate the location of the linkage of the group containing the * to the rest of the compound, R 6 is a carbyl group for a′=1 and for a′=0 is selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl; Sp is selected from the group consisting of alkanediyl, alkenediyl and alkyndiyl having at least 10 carbon atoms and at most 20 carbon atoms; X 1 and X 2 are independently of each other selected from the group consisting of O, S and N—R 17 ; X 3 is O or S; R 10 , R 11 , R 12 , R 13 and R 14 are at each occurrence independently of each other selected from the group consisting of H, F, Cl, Br, I, R 6 -Sp-[X 1 ] a *, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl, provided that at least one of R 10 , R 11 , R 12 , R 13 and R 14 is R 15 ; R 15 is at each occurrence independently selected from the group consisting of alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, alkoxy having from 1 to 20 carbon atoms, partially or completely halogenated alkoxy having from 1 to 20 carbon atoms, thioalkyl having from 1 to 20 carbon atoms, and partially or completely halogenated thioalkyl having from 1 to 20 carbon atoms; and R 17 is at each occurrence independently selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl, provided that the compound of formula (I) comprises one group R 6 -Sp-[X 1 ] a -*. 2. The intraocular lens article according to claim 1 , wherein said compound of formula (I) is a compound of formula (I′) wherein one of R 4 and R 5 is a group of formula (II) and the other of R 4 and R 5 is selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl; R 6 is a carbyl group; and R 10 , R 11 , R 12 , R 13 and R 14 are at each occurrence independently of each other selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl, provided that at least one of R 10 , R 11 , R 12 , R 13 , and R 14 is R 15 , and wherein any two groups of R 10 , R 11 , R 12 , R 13 and R 14 that are R 15 may also form a ring system. 3. The intraocular lens article according to claim 1 , wherein said compound of formula (I) is a compound of formula (I″) wherein one of R 4 and R 5 is a group of formula (II) and the other of R 4 and R 5 is selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl; R 6 is selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl; and one of R 10 , R 11 , R 12 , R 13 and R 14 is R 6 -Sp-[X 1 ] a *, with the others at each occurrence independently of each other selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl, provided that at least one of R 10 , R 11 , R 12 , R 13 and R 14 is R 15 , wherein any two adjacent groups of R 10 , R 11 , R 12 , R 13 and R 14 that are R 15 may also form a ring system. 4. The intraocular lens article according to claim 1 , wherein said compound of formula (I) is a compound of formula (I″) wherein one of R 4 and R 5 is a group of formula (II) and the other of R 4 and R 5 is R 6 -Sp-[X 1 ] a —*; R 6 is selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl; and R 10 , R 11 , R 12 , R 13 and R 14 are at each occurrence independently of each other selected from the group consisting of H, F, Cl, Br, I, alkyl having from 1 to 20 carbon atoms, partially or completely halogenated alkyl having from 1 to 20 carbon atoms, aryl and heteroaryl, provided that at least one of R 10 , R 11 , R 12 , R 13 and R 14 is R 15 , wherein any two adjacent groups of R 10 , R 11 , R 12 , R 13 and R 14 that are R 15 may also form a ring system. 5. The intraocular lens article according to claim 1 , wherein, in the compound of formula (I), R 1 , R 2 and R 3 are H. 6. The intraocular lens article according to claim 1 , wherein, in the compound of formula (I), R 4 is H and R 5 is a group of formula (II). 7. The intraocular lens article according to claim 1 , wherein, in the compound of formula (I), those of R 10 , R 11 , R 12 , R 13 and R 14 that are not R 15 are H. 8. The intraocular lens article according to claim 1 , wherein, in the compound of formula (I), Sp is selected from the group consisting of alkanediyl, alkenediyl and alkyndiyl, wherein at least one hydrogen has been replaced with R 16 , with R 16 being selected from the group consisting of OH, alkyl having from 1 to 10 carbon atoms, partially or completely halogenated alkyl having from 1 to 10 carbon atoms, alkoxy having from 1 to 10 carbon atoms, and partially or completely halogenated alkoxy having from 1 to 10 carbon atoms. 9. The intraocular lens article according to claim 1 , wherein, in the compound of formula (I), Sp is of formula (III) —[C(R 7 )(R 8 )] b — (III) wherein b is at least 1; and R 7 and R 8 are independently of each other H or R 16 , provided that at l
Esters containing sulfur · CPC title
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
substituted in position 7 · CPC title
Lenses · CPC title
Esters of unsaturated alcohols {, e.g. allyl (meth)acrylate} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.